期刊
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
卷 184, 期 1, 页码 64-74出版社
AMER THORACIC SOC
DOI: 10.1164/rccm.201010-1585OC
关键词
lymphopenia; IL-2; Bcl-2; PI3K; PTEN; GW9662
资金
- Deutsche Forschungsgemeinschaft (DFG) [KN 493/9-1, Br999]
- Sonderforschungsbereich 815 [SFB815 TP3]
- German Research Association
Rationale: Despite intensive research, sepsis displays the most prevalent cause of death on intensive care units. The hallmark of sepsis is an overshooting T-cell death that reduces host defense mechanisms and that is associated with poor patient survival. Previous in vitro studies revealed that the expression of the transcription factor peroxisome proliferator-activated receptor (PPAR) gamma was increased in isolated T cells of patients with sepsis. Objectives: We determined the importance of targeting PPAR gamma for sepsis treatment and underlying molecular mechanisms for T-cell apoptosis in vivo. Methods: To mimic human systemic inflammation and septic conditions, we used a nonlethal endotoxemia and a lethal cecum ligation and puncture polymicrobial sepsis model. Measurements and Main Results: PPAR gamma inhibition in T cells with either the PPAR gamma antagonist GW9662 or a newly generated T cell-specific PPAR gamma knockout (Tc-PPAR gamma(-/-)) mice provided a survival advantage during polymicrobial sepsis in mice, which correlated with abrogated T-cell depletion in both in vivo models. Pathway analysis revealed increased antiapoptotic IL-2 and Bcl-2 expression, and activated prosurvival PI3K/Akt signaling under PPAR gamma-deficient conditions. In line, neutralizing IL-2 in Tc-PPAR gamma(-/-) mice resulted in T-cell apoptosis and increased mortality. Conclusions: Our results provide evidence fora pivotal involvement of PPAR gamma in T-cell depletion by activating two important apoptosis pathways, and subsequently provoking the breakdown of defense mechanisms during systemic inflammation and sepsis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据